Hemihypertrophy

Lore & Background

Hemihypertrophy is a condition where one side of the body or a part of one side is larger than the other, with asymmetry ranging from mild to severe. Diagnosis can be difficult, and clinicians often rely on the dictum that the asymmetry should be visible 'from the end of the bed'. The condition is congenital and is seen in several syndromes, including Beckwith-Wiedemann syndrome and Russell-Silver syndrome.

Reader's Guide

The significance of hemihypertrophy lies in its association with an increased risk for embryonal tumors, primarily Wilms tumor and hepatoblastoma. Because of this heightened risk, a tumor screening protocol is recommended for all children with isolated hemihypertrophy and Beckwith-Wiedemann syndrome. The protocol includes referral to a clinical geneticist, abdominal ultrasound every three months until age seven, serum alpha fetoprotein measurement every three months until age four, and daily caretaker abdominal examination at the discretion of the provider or parent. Children may also develop scoliosis or leg length discrepancies. Surgical options for leg length differences include epiphysiodesis for growing patients and bone resection for those who have stopped growing; leg lengthening via Ilizarov's method is reserved for discrepancies greater than four centimeters. Hemifacial hyperplasia is considered a minor form of hemihypertrophy.

Did You Know?

• Hemihypertrophy is now more commonly referred to as hemihyperplasia in medical literature.
• The condition is associated with an increased risk for Wilms tumor and hepatoblastoma.
• A tumor screening protocol includes abdominal ultrasound every three months until age seven.
• Hemifacial hyperplasia is believed to be a minor form of hemihypertrophy.

Definition and Clinical Recognition

Hemihypertrophy, a term that has largely given way to the label hemihyperplasia in current medical writing, describes a congenital condition in which one side of the body—or a portion of one side—grows to a size that exceeds the other beyond what is considered normal variation. Because drawing a precise clinical line between ordinary asymmetry and true overgrowth is inherently difficult, practitioners have long relied on a practical rule of thumb: the size difference should be visually apparent even when viewed from the far end of a hospital bed. The condition exists on a spectrum, with manifestations ranging from subtle to dramatically pronounced. It is not a single isolated anomaly but rather a feature that appears within several recognized congenital syndromes, most notably Beckwith-Wiedemann syndrome and Russell-Silver syndrome. Recognizing hemihyperplasia early is critical not merely for cosmetic or functional reasons but because it signals an elevated vulnerability to certain childhood cancers, making prompt identification a matter of genuine clinical urgency.

Tumor Surveillance Protocol

One of the most consequential aspects of a hemihyperplasia diagnosis is the significantly elevated risk of embryonal tumors, particularly Wilms tumor and hepatoblastoma. Because of this association, a structured tumor-screening protocol is recommended for every child presenting with isolated hemihyperplasia as well as those diagnosed with Beckwith-Wiedemann syndrome, and in some cases, other syndromes that include hemihyperplasia as a feature. The protocol begins with a mandatory referral to a clinical geneticist for comprehensive evaluation. Following that, abdominal ultrasound examinations are scheduled at three-month intervals and continue until the child reaches seven years of age. In parallel, serum alpha-fetoprotein levels are measured every three months until the child is four. Beyond these scheduled tests, daily abdominal palpation by a caretaker is left to the discretion of the treating provider or the family. This layered surveillance approach reflects the medical community's recognition that early detection of a developing tumor can be the difference between a manageable intervention and a far more serious outcome.

Managing Leg-Length Discrepancy

When hemihyperplasia produces a noticeable difference in leg length, treatment options fall into surgical and nonsurgical categories. For patients who still have remaining growth potential, epiphysiodesis is a common approach: a portion of the growth plate on the longer leg is removed, effectively slowing its growth so the shorter leg can gradually catch up. In patients whose growth plates have closed, bone resection—removing a segment of the longer bone—becomes the shortening procedure of choice. Lengthening procedures, by contrast, are considerably more painful and invasive. They involve inserting pins into the bone and gradually turning them to separate bone segments, a technique rooted in Ilizarov's method. These procedures are typically reserved for discrepancies exceeding four centimetres, though some are now performed for cosmetic reasons. For milder cases, a simple nonsurgical solution—a lift attached to the shoe on the shorter side—can restore a normal gait without any operative intervention.

Broader Clinical Manifestations and Related Conditions

Beyond the primary asymmetry and its tumor-related risks, hemihypertrophy can manifest in additional ways that affect a child's development and daily life. Scoliosis, an abnormal curvature of the spine, is a recognized complication that may develop in children with the condition, adding another layer of orthopedic concern to an already complex clinical picture. The condition also exists on a broader spectrum of overgrowth presentations. Hemifacial hyperplasia, in which only one side of the face is enlarged, is generally regarded as a minor or localized form of hemihypertrophy, suggesting that the underlying mechanisms of asymmetric growth can affect the body at varying scales. The fact that hemihyperplasia appears as a shared feature across multiple distinct congenital syndromes—each with its own constellation of findings—underscores that the condition is best understood not as a standalone diagnosis but as a clinical sign pointing toward a wider genetic or developmental picture. This interconnectedness is precisely why geneticist referral and multidisciplinary care remain central to managing affected children.